Adiponectin is a cardioprotective adipokine that dampens endogenous hepatic glucose production, improves insulin sensitivity, negatively correlates with body mass, and is often decreased in the presence of insulin resistance and/or diabetes mellitus [64,65]. Here, ADIPOQ is linked to Insulin resistance.